These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1667361)

  • 1. Platelet-derived growth factor: a general review with emphasis on astrocytomas.
    Guha A
    Pediatr Neurosurg; 1991-1992; 17(1):14-20. PubMed ID: 1667361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance.
    Maxwell M; Naber SP; Wolfe HJ; Galanopoulos T; Hedley-Whyte ET; Black PM; Antoniades HN
    J Clin Invest; 1990 Jul; 86(1):131-40. PubMed ID: 2164040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factor PDGF-B/v-sis confers a tumorigenic phenotype to human tumor cells bearing PDGF receptors but not to cells devoid of receptors: evidence for an autocrine, but not a paracrine, mechanism.
    Potapova O; Fakhrai H; Mercola D
    Int J Cancer; 1996 May; 66(5):669-77. PubMed ID: 8647631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop.
    Guha A; Dashner K; Black PM; Wagner JA; Stiles CD
    Int J Cancer; 1995 Jan; 60(2):168-73. PubMed ID: 7829210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops.
    Hermanson M; Funa K; Hartman M; Claesson-Welsh L; Heldin CH; Westermark B; Nistér M
    Cancer Res; 1992 Jun; 52(11):3213-9. PubMed ID: 1317261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor in human malignancy.
    Silver BJ
    Biofactors; 1992 Apr; 3(4):217-27. PubMed ID: 1318717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of platelet-derived growth factor (PDGF) B chain and PDGF B-type receptor in human gliomas.
    Mauro A; Bulfone A; Turco E; Schiffer D
    Childs Nerv Syst; 1991 Dec; 7(8):432-6. PubMed ID: 1665101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
    Potapova O; Fakhrai H; Baird S; Mercola D
    Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
    Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
    Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived growth factor in human glioma.
    Westermark B; Heldin CH; Nistér M
    Glia; 1995 Nov; 15(3):257-63. PubMed ID: 8586462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction pathways and their relevance in human astrocytomas.
    Feldkamp MM; Lau N; Guha A
    J Neurooncol; 1997 Dec; 35(3):223-48. PubMed ID: 9440022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells.
    Shamah SM; Stiles CD; Guha A
    Mol Cell Biol; 1993 Dec; 13(12):7203-12. PubMed ID: 8246942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis.
    Shih AH; Dai C; Hu X; Rosenblum MK; Koutcher JA; Holland EC
    Cancer Res; 2004 Jul; 64(14):4783-9. PubMed ID: 15256447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of an activated platelet-derived growth factor autocrine pathway and its role in human tumor cell proliferation in vitro.
    Fleming TP; Matsui T; Heidaran MA; Molloy CJ; Artrip J; Aaronson SA
    Oncogene; 1992 Jul; 7(7):1355-9. PubMed ID: 1320245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor (PDGF) and glial tumorigenesis.
    Shih AH; Holland EC
    Cancer Lett; 2006 Feb; 232(2):139-47. PubMed ID: 16139423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains.
    Beckmann MP; Betsholtz C; Heldin CH; Westermark B; Di Marco E; Di Fiore PP; Robbins KC; Aaronson SA
    Science; 1988 Sep; 241(4871):1346-9. PubMed ID: 2842868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action and in vivo role of platelet-derived growth factor.
    Heldin CH; Westermark B
    Physiol Rev; 1999 Oct; 79(4):1283-316. PubMed ID: 10508235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGF and PDGF receptors in glioma.
    Nazarenko I; Hede SM; He X; Hedrén A; Thompson J; Lindström MS; Nistér M
    Ups J Med Sci; 2012 May; 117(2):99-112. PubMed ID: 22509804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor. Structure, function and implications in normal and malignant cell growth.
    Westermark B; Heldin CH
    Acta Oncol; 1993; 32(2):101-5. PubMed ID: 8323751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.